Open AccessA COMPARATIVE EXPECTED VALUE ANALYSIS STUDY TO DETERMINE IF THE ECONOMIC BENEFITS OF THE MOST COMMONLY PRESCRIBED PRESCRIPTION AND NON-PRESCRIPTION DRUGS IN THE UNITED STATES PROVIDE ECONOMIC VALUE
Author(s) -
S. Eric Anderson
Publication year - 2021
Publication title -
account and financial management journal
Language(s) - English
Resource type - Journals
ISSN - 2456-3374
DOI - 10.47191/afmj/v6i10.02
Subject(s) - medical prescription , medicine , pill , value (mathematics) , aspirin , clopidogrel , economic analysis , diabetes mellitus , depression (economics) , intensive care medicine , pharmacology , economics , statistics , mathematics , agricultural economics , endocrinology , macroeconomics
It was found that anti-biotics, aspirin, bisphosphonates, blood pressure lowering medications, statins, medications treating depression, diabetes, sexual dysfunction and the poly-pill provided economic value, while medications to treat Alzheimer’s, cancer, multiple sclerosis and Clopidogrel were not found to have provided economic value. The current evidence is insufficient to determine if weight loss medication provides economic value or not